IKT Past Earnings image   This IKT past earnings page last updated 3/6/2024
IKT Past Earnings
PeriodPast Earnings DateGAAP
Q3 202311/14/2023-0.860
Q2 20238/14/2023-1.110
Q1 20235/15/2023-0.960
Q4 20223/31/2023-1.020
Q3 202211/14/2022-1.080
Q2 20228/12/2022-1.080
Q1 20225/16/2022-1.080
Q4 20213/31/2022-1.200
Q3 202111/15/2021-1.080
Q2 20218/16/2021-1.320
Q1 20215/17/2021-1.560
Q4 20204/1/2021-0.900
IKT Past Revenue
PeriodPast Earnings DateGAAP
Q3 202311/14/20230.08M
Q2 20238/14/20230.00B
Q1 20235/15/20230.06M
Q4 20223/31/20230.06M
Q3 202211/14/20220.01M
Q2 20228/12/20220.01M
Q1 20225/16/20220.05M
Q4 20213/31/20220.00B
Q3 202111/15/20210.00B
Q2 20218/16/20210.00B
Q1 20215/17/20210.00B
Q4 20204/1/20210.00B
Quotes delayed 20 minutes

Email EnvelopeFree IKT Email Alerts:
Get Dividend Alerts
Get SEC Filing Alerts
10 Most Oversold S&P 500 Stocks
10 Most Overbought S&P 500 Stocks
10 ETFs With Stocks Insiders Are Buying
10 ETFs With Most Upside To Targets
The DividendRank Top 25
Warren Buffett Dividend Stocks
10 Cheap Dividend Stocks Under $10
10 Top DividendRank'ed Energy Stocks
The 10 Highest Yielding Preferred Stocks
The 10 Highest Yielding Preferred Stocks
The 15 Most Active S&P Call & Put Options
Inhibikase Therapeutics (IKT) is categorized under the Healthcare sector; to help you further research past earnings across stocks, below are some other companies in the same sector:

ILMN Past Earnings
IMAC Past Earnings
IMGN Past Earnings
IMGO Past Earnings
IMMX Past Earnings
IMNM Past Earnings
IMNN Past Earnings
IMPL Past Earnings
IMRA Past Earnings
IMRX Past Earnings

IKT Past Earnings Q&A

What was the best and worst IKT past earnings results?
For Inhibikase Therapeutics, I'm wondering what the company's very best and worst earnings results have been, on an earnings per share basis?

✔️Accepted answer: The highest IKT past earnings result in our data set was -0.860/share posted in Q3 2023, while the lowest was in Q1 2021 when IKT posted -1.560/share.

  Suggested answer: The biggest top line earnings performance — aka revenue — quarter was in Q4 2021 when IKT reported 0.00B in revenue, while the quarter with the lowest revenue in our data set was Q2 2022 at 0.01M of revenue.

  Suggested answer: There are 12 IKT past earnings results in our data set.

On this page we presented the IKT past earnings date information for Inhibikase Therapeutics. Reviewing that IKT Past Earnings for the company, we see that the highest past earnings result in our data set was in Q3 2023, when IKT posted gaap of -0.860/share. Meanwhile the lowest IKT past earnings result was in Q1 2021, when IKT posted gaap of -1.560/share. Turning to top line revenue performance, the biggest revenue quarter in our data set was seen in Q4 2021 when IKT reported 0.00B in revenue, while the smallest revenue quarter was Q2 2022 when IKT reported 0.01M in revenue.

Any self directed investor doing their due diligence on IKT or any other given stock can benefit from researching all of the Inhibikase Therapeutics past earnings — and here, we present each quarter's result all together on one page for easy comparison. Studying this information can help when projecting future earnings, as well as determining whether the past earnings trajectory justifies the current stock value. That's why we bring you PastEarnings.com to make it easy for investors to investigate Inhibikase Therapeutics past earnings, or the past earnings information for any stock in our coverage universe. And in your continued research we hope you will be sure to check out the further links included for earnings surprises history (beat/miss data) as well as next earnings dates for IKT. Thanks for visiting, and the next time you need to research IKT past earnings or those of another stock, we hope you'll think of our site, as your go-to past earnings research resource of choice.

Recommended: COLM Dividend History, Funds Holding VGM, ACRE YTD Return.


IKT Past Earnings | www.PastEarnings.com | Copyright © 2020 - 2024, All Rights Reserved

Nothing in PastEarnings.com is intended to be investment advice, nor does it represent the opinion of, counsel from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners. None of the information contained herein constitutes a recommendation that any particular security, portfolio, transaction, or investment strategy is suitable for any specific person. All viewers agree that under no circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you agree to the following Full Disclaimer & Terms of Use and Privacy Policy. Video widget and market videos powered by Market News Video. Quote and option data delayed at least 15 minutes; stock quote data powered by Ticker Technologies, and Mergent.
Wait! Don't leave yet.
Want to receive our latest research absolutely free?

Click the button below for your complimentary copy of Your Early Retirement Portfolio: Dividends Up to 9.5%—Every Month—Forever.

You'll discover the details on 4 stocks and funds that pay you massive dividends as high as 9.5%.